Search Results - "HEEG, B." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Precision of mono-exponential decay estimates from rapid lifetime determination in the presence of signal photon and background noise

Precision of mono-exponential decay estimates from rapid lifetime determination in the presence of signal photon and background noise

by Heeg, B
Published in Measurement science & technology (01.10.2014)

Get full text

Journal Article

Precision of least-squares mono-exponential decay time estimates from optical measurements with both photon shot noise and background noise

Precision of least-squares mono-exponential decay time estimates from optical measurements with both photon shot noise and background noise

by Heeg, B
Published in Measurement science & technology (01.12.2013)

Get full text

Journal Article

Cost-Effectiveness of Bosutinib for the Treatment of Adult Patients with Chronic Phase Chronic Myeloid Leukemia in the Second-Line Setting

Cost-Effectiveness of Bosutinib for the Treatment of Adult Patients with Chronic Phase Chronic Myeloid Leukemia in the Second-Line Setting

by Muresan, B., Mamolo, C., Cappelleri, J. C., Postma, M. J., Heeg, B.
Published in Applied health economics and health policy (01.11.2021)

Get full text

Journal Article

Clinical Trial Simulation Considering Quality Of Life Outcomes

Clinical Trial Simulation Considering Quality Of Life Outcomes

by Mohseninejad, L, Heeg, B, Majer, I.M
Published in Value in health (01.11.2014)

Get full text

Journal Article

Joint Modelling Of The Change In Tumor Size And Overall Survival; A Parametric Model Considering Patient Heterogeneity Not Observed At Baseline

Joint Modelling Of The Change In Tumor Size And Overall Survival; A Parametric Model Considering Patient Heterogeneity Not Observed At Baseline

by Majer, I.M, Heeg, B
Published in Value in health (01.11.2014)

Get full text

Journal Article

$Cost-Effectiveness of Inotuzumab Ozogamicin Compared to Standard of Care Chemotherapy for Treating Relapsed or Refractory Acute Lymphoblastic Leukaemia Patients in Norway and Sweden$

Cost-Effectiveness of Inotuzumab Ozogamicin Compared to Standard of Care Chemotherapy for Treating Relapsed or Refractory Acute Lymphoblastic Leukaemia Patients in Norway and Sweden

by van Oostrum, I., Russell-Smith, T. A., Jakobsson, M., Torup Østby, J., Heeg, B.
Published in PharmacoEconomics - open (01.01.2022)

Get full text

Journal Article

PRM44 Increasing Life Expectancy: Implications for Cost-Effectiveness Analysis

PRM44 Increasing Life Expectancy: Implications for Cost-Effectiveness Analysis

by Majer, I.M, Heeg, B
Published in Value in health (01.11.2012)

Get full text

Journal Article

The Proportional Odds Model Is More Efficient Than The Multinomial Logistic Model For Network Meta-Analyses Of Ordered Outcomes

The Proportional Odds Model Is More Efficient Than The Multinomial Logistic Model For Network Meta-Analyses Of Ordered Outcomes

by Bouwmeester, W, van Beurden-Tan, C, Bennison, C, Heeg, B
Published in Value in health (01.11.2014)

Get full text

Journal Article

Predictors of German Amnog Decisions and GKV Rebate Negotiations: A Database Analysis

Predictors of German Amnog Decisions and GKV Rebate Negotiations: A Database Analysis

by Verleger, K, Schoeman, O, Schmidt, R, Wilke, T, Heeg, B
Published in Value in health (01.11.2014)

Get full text

Journal Article

The Impact of Amnog on Drug Reimbursement in Germany

The Impact of Amnog on Drug Reimbursement in Germany

by Heeg, B, Schoeman, O, Mueller, S, Wilke, T
Published in Value in health (01.11.2013)

Get full text

Journal Article

A Model to Evaluate the Immunogenicity Costs of Tumour Necrosis Factor-Alpha Inhibitors in Patients with Rheumatoid Arthritis

A Model to Evaluate the Immunogenicity Costs of Tumour Necrosis Factor-Alpha Inhibitors in Patients with Rheumatoid Arthritis

by Heeg, B, Majer, I, Stephens, J.M, Tarallo, M
Published in Value in health (01.11.2013)

Get full text

Journal Article

$Economic evaluation of zoledronic acid for the prevention of osteoporotic fractures in postmenopausal women with early-stage breast cancer receiving aromatase inhibitors in the UK$

Economic evaluation of zoledronic acid for the prevention of osteoporotic fractures in postmenopausal women with early-stage breast cancer receiving aromatase inhibitors in the UK

by Logman, J.F.S., Heeg, B.M.S., Botteman, M.F., Kaura, S., van Hout, B.A.
Published in Annals of oncology (01.07.2010)

Get full text

Journal Article

Comparison of Mean Overall Survival (OS) and Radiographic Progression Free Survival (RPFS) Based on Matching Adjusted Indirect Comparison of Abiraterone Acetate and Enzalutamide for the Treatment of Castration-Resistant Prostate Cancer in Chemotherapy Naïve Patients

Comparison of Mean Overall Survival (OS) and Radiographic Progression Free Survival (RPFS) Based on Matching Adjusted Indirect Comparison of Abiraterone Acetate and Enzalutamide for the Treatment of Castration-Resistant Prostate Cancer in Chemotherapy Naïve Patients

by Dearden, L, Majer, I, Heeg, B, Liwing, J, Sandstrom, K, Diels, J
Published in Value in health (01.11.2014)

Get full text

Journal Article

Determinants of Increasing the Likelihood for a Positive Drug Reimbursement Recommendation in Scotland

Determinants of Increasing the Likelihood for a Positive Drug Reimbursement Recommendation in Scotland

by Pantiri, K, Baeten, S, Majer, I.M, Heeg, B, Charokopou, M
Published in Value in health (01.11.2014)

Get full text

Journal Article

Factors Influencing Dutch Drug Reimbursement Recommendations; A Database Analysis

Factors Influencing Dutch Drug Reimbursement Recommendations; A Database Analysis

by Alleman, C.J.M, Spoorendonk, J.A, Charokopou, M, Hensen, M, Heeg, B
Published in Value in health (01.11.2014)

Get full text

Journal Article

Review of Meta-Analysis Methods for Multinomial Data

Review of Meta-Analysis Methods for Multinomial Data

by Bennison, C, van Beurden-Tan, C, Buyukkaramikli, C, Heeg, B
Published in Value in health (01.11.2013)

Get full text

Journal Article

RE1 Factors Influencing Drug Reimbursement Decision in Scotland

RE1 Factors Influencing Drug Reimbursement Decision in Scotland

by Charokopou, M, Heeg, B, Majer, I.M
Published in Value in health (01.11.2012)

Get full text

Journal Article

A Comparison of Factors Influencing Reimbursement and Coverage Decisions in Scotland (Smc), The Netherlands (Nzi) and Germany (G-Ba)

A Comparison of Factors Influencing Reimbursement and Coverage Decisions in Scotland (Smc), The Netherlands (Nzi) and Germany (G-Ba)

by Charokopou, M, Alleman, C.J.M, Verleger, K, Spoorendonk, J.A, Schmidt, R, Schoeman, O, Heeg, B
Published in Value in health (01.11.2014)

Get full text

Journal Article

A Comparison of Coverage and Reimbursement Decisions in Germany (AMNOG) and Scotland (SMC)

A Comparison of Coverage and Reimbursement Decisions in Germany (AMNOG) and Scotland (SMC)

by Charokopou, M, Heeg, B, Schoeman, O, Mueller, S, Tempest, M.J, Schlagmüller, S.C, Wilke, T
Published in Value in health (01.11.2013)

Get full text

Journal Article

The cost-effectiveness of paliperidone extended release in Spain

The cost-effectiveness of paliperidone extended release in Spain

by Treur, M, Baca, E, Bobes, J, Cañas, F, Salvador, L, Gonzalez, B, Heeg, B
Published in Journal of medical economics (01.11.2012)

Get more information

Journal Article

1
2
3
4
5
6
7
8
9
10
11
Next
[11]